Primary Myelofibrosis Completed Phase 2 Trials for Momelotinib (DB11763)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01236638Extension Study Evaluating the Long Term Safety and Efficacy Study of CYT387 in Primary Myelofibrosis (PMF) or Post-polycythemia Vera (PV) or Post-essential Thrombocythemia (ET)Treatment